RESUMEN
OBJECTIVE: Urea is commonly used as a keratolytic substance in the treatment of onychomycoses to improve the penetration of antifungal drugs in the lesion sites. The aim of the present study was to investigate the inhibitory action of urea on samples of dermatophytes in vitro. METHOD: Minimum inhibitory concentration of urea was determined for 31 samples of dermatophytes cultured in Sabouraud-dextrose broth containing different concentrations (7.5% up to 40%) of urea. Absence of growth was the criterion adopted to determine the minimum inhibitory concentration. RESULTS: The majority of samples (87%) were sensitive to urea at 12.5%, or less. 2 isolates of Trichophyton tonsurans and 2 of Trichophyton rubrum required 30%, and 40% urea, respectively, to be completely inhibited. CONCLUSION: In vitro results demonstrate inhibitory activity of urea on dermatophytes, suggesting that it could be used as an adjuvant in topical treatments.
Asunto(s)
Antifúngicos/farmacología , Queratolíticos/farmacología , Microsporum/efectos de los fármacos , Trichophyton/efectos de los fármacos , Urea/farmacología , Medios de Cultivo , Humanos , Pruebas de Sensibilidad MicrobianaRESUMEN
Our purpose was to compare the genetic polymorphism of six samples of P. brasiliensis (113, 339, BAT, T1F1, T3B6, T5LN1), with four samples of P. cerebriformis (735, 741, 750, 361) from the Mycological Laboratory of the Instituto de Medicina Tropical de São Paulo, using Random Amplified Polymorphic DNA Analysis (RAPD). RAPD profiles clearly segregated P. brasiliensis and P. cerebriformis isolates. However, the variation on band patterns among P. cerebriformis isolates was high. Sequencing of the 28S rDNA gene showed nucleotide conservancy among P. cerebriformis isolates, providing basis for taxonomical grouping, and disclosing high divergence to P. brasiliensis supporting that they are in fact two distinct species. Moreover, DNA sequence suggests that P. cerebriformis belongs in fact to the Aspergillus genus.
Asunto(s)
ADN de Hongos/aislamiento & purificación , ADN Ribosómico/genética , Paracoccidioides/genética , Polimorfismo Genético/genética , Secuencia de Bases , ADN de Hongos/genética , Humanos , Datos de Secuencia Molecular , Paracoccidioides/clasificación , Reacción en Cadena de la Polimerasa , Técnica del ADN Polimorfo Amplificado Aleatorio , Análisis de Secuencia de ADN/métodos , Especificidad de la EspecieRESUMEN
OBJECTIVE: To evaluate voriconazole in the treatment of extensive cases of chromomycosis. Chromomycosis is a chronic infection, which is extremely difficult to eradicate, and is caused by dematiaceous (dark-colored) fungi which affect the skin and subcutaneous tissues, with Fonsecaea pedrosoi being the major etiologic agent. Drugs such as itraconazole, terbinafine, posaconazole and amphotericin B have been employed with variable results. METHODS: We treated three Caucasian male patients (ages 44, 57 and 77 years), two were farmers and one a trash collector, with long-standing (20, 10 and 21 years of disease, respectively) and extensive chromomycosis (one lower limb affected, at least) due to Fonsecaea pedrosoi. All patients had received previous therapy with the formerly indicated drugs itraconazole and terbinafine for several months either without or with incomplete response. After that, we started treatment with voriconazole per os 200 mg twice a day. RESULTS: The patients were treated with voriconazole for 12 months until there was clinical and mycological improvement. Clinical response was evident after 30-50 days. One patient developed visual abnormalities and tremors, and the voriconazole was reduced to 200 mg/day without impairment of the clinical and mycological response. The same patient presented photosensitive dermatitis after 12 months of therapy and the voriconazole was stopped. All patients showed elevations of serum gamma-glutamyl transpeptidase (GGT) during the treatment without clinical relevance. Moreover, our three patients obtained partial response with this therapy. CONCLUSIONS: This is the first report with a case series of chromomycosis treated with voriconazole. Despite its high cost, voriconazole is a safe and possibly promising drug for use on extensive chromomycosis refractory to conventional treatment.
Asunto(s)
Antifúngicos/uso terapéutico , Ascomicetos , Cromoblastomicosis/tratamiento farmacológico , Pirimidinas/uso terapéutico , Triazoles/uso terapéutico , Adulto , Anciano , Cromoblastomicosis/microbiología , Humanos , Masculino , Persona de Mediana Edad , VoriconazolRESUMEN
BACKGROUND: Even though porphyria cutanea tarda is the most frequent type of porphyria, there are few studies about its cutaneous physiopathology. OBJECTIVE: To evaluate skin changes in porphyria cutanea tarda using light microscopy and direct immunofluorescence before and after treatment with chloroquine. To perform antigen immunomapping of bullae to study their level of cleavage. METHODS: Light microscopy and direct immunofluorescence of 28 patients are reported in three different phases: 23 patients with active porphyria before treatment (Phase A), 7 patients with clinical remission during treatment (Phase B), and 8 patients with biochemical remission (Phase C). Immunomapping was performed on 7 patients. RESULTS: In active porphyria, direct immunofluorescence showed homogenous and intense fluorescence on the inside and on the walls of blood vessels as well as in the dermal-epidermal junction. In clinical remission (Phase B) and biochemical remission (Phase C), the deposit of immunoglobulins was maintained, but the deposit of complement was reduced in most cases. Immunomapping revealed no standard cleavage plane. CONCLUSION: No correlation was observed between clinical response and immunoglobulin deposits. The reduction of complement favors the hypothesis that activation of the complement cascade represents an additional pathway that leads to endothelial damage.
Asunto(s)
Porfiria Cutánea Tardía/fisiopatología , Adolescente , Adulto , Anciano , Anticuerpos Monoclonales/inmunología , Antígenos/inmunología , Cloroquina/uso terapéutico , Estudios Transversales , Fármacos Dermatológicos/uso terapéutico , Femenino , Técnica del Anticuerpo Fluorescente Directa , Humanos , Masculino , Microscopía/métodos , Persona de Mediana Edad , Porfiria Cutánea Tardía/tratamiento farmacológico , Porfiria Cutánea Tardía/inmunología , Adulto JovenRESUMEN
Lacazia loboi, the aetiological agent of lacaziosis (Jorge Lobo's disease), is an uncultivated anomalous fungal microbe closely related to Paracoccidioides brasiliensis, both restricted Latin American Pathogens. Early reports suggesting that L. loboi had been isolated in pure culture from cases of lacaziosis, only added more confusion to the already confusing aetiology of this disease. These strains were later identified as unusual contaminants and some of them as P. brasiliensis. Recent phylogenetic analysis grouped L. loboi as the sister taxon to P. brasiliensis, thus it was postulated that the original P. brasiliensis strains recovered from cases of lacaziosis, could be the aetiological agent of the disease. Using molecular methodologies, we investigated the archival P. brasiliensis isolate No. 525 from a case of lacaziosis, as well as other archival isolates, identified earlier as common contaminants, all recovered from similar cases of the disease. Phylogenetic analysis, using the 18S small subunit rDNA sequences of these isolates showed that strain No. 525 was a typical P. brasiliensis isolate and the other studied strains were indeed contaminants. This study unequivocally indicates that the aetiological agent of lacaziosis is yet to be cultured.
Asunto(s)
Micosis/microbiología , Onygenales , Paracoccidioides , Paracoccidioidomicosis/microbiología , Filogenia , ARN Ribosómico 18S/genética , Análisis de Secuencia de ADN , Aspergillus/clasificación , Aspergillus/genética , Aspergillus/aislamiento & purificación , Basidiomycota/clasificación , Basidiomycota/genética , Basidiomycota/aislamiento & purificación , Brasil , ADN de Hongos/análisis , ADN Ribosómico/análisis , Humanos , Datos de Secuencia Molecular , Onygenales/clasificación , Onygenales/genética , Onygenales/aislamiento & purificación , Paracoccidioides/clasificación , Paracoccidioides/genética , Paracoccidioides/aislamiento & purificación , Reacción en Cadena de la Polimerasa , Factores de TiempoRESUMEN
Cryptococcus neoformans is an encapsulated fungal organism that can cause disease in apparently immunocompetent, as well as immunocompromised, hosts. Since 1930, successive subculture has been used to preserve C. neoformans isolates in our Fungus Collection. In the 1970s, some of these Fungus Collection samples were selected to be subjected to a different methods of maintenance--that of lyophilized. Our objective was to analyze C. neoformans isolates in order to make a comparative evaluation between these two methods of preservation. The overall aim of this study was to qualify the preservation technique used in our mycology laboratory since the technique used might affect the survival, stability and purity of the primary isolates in culture. The samples were analyzed using classical mycology methods and using the randomly amplified polymorphic DNA technique In the analysis of phenotypes and genotypes, the typical characteristics of C. neoformans were found to differ in relation to the different methods of preservation employed. The aim of this study was to demonstrate the importance of selecting the appropriate method of preservation for fungus collections. This selection can affect the survival and purity of the cultures, and preserve the stability of their physiological, biochemical, and genetic characteristics.
Asunto(s)
Cryptococcus neoformans/genética , ADN de Hongos/análisis , Preservación Biológica/métodos , Cryptococcus neoformans/fisiología , Liofilización , Genotipo , Humanos , Fenotipo , Reacción en Cadena de la Polimerasa , Técnica del ADN Polimorfo Amplificado Aleatorio , Factores de TiempoRESUMEN
The aim of this study was to demonstrate the DNA of Paracoccidioides brasiliensis in human serum samples of patients with paracoccidioidomycosis using the polymerase chain reaction (PCR). The diagnosis of paracoccidioidomycosis (PCM) was defined by microscopic observation of the fungus on direct exam or histopathology, culture, and serological positivity. DNA from serum of 33 patients with PCM was extracted and submitted to nested-PCR using primers from the gp 43 gene. Only one sample was positive on nested-PCR. We conclude that the prevalence of fungemia in patients with different clinical forms of PCM is low, limiting the use of serum DNA detection as an alternative diagnostic tool.
Asunto(s)
Antígenos Fúngicos/genética , ADN de Hongos/análisis , Proteínas Fúngicas/genética , Fungemia/diagnóstico , Glicoproteínas/genética , Paracoccidioides/genética , Paracoccidioidomicosis/sangre , Reacción en Cadena de la Polimerasa/métodos , Adulto , Anciano , Niño , Cartilla de ADN , ADN de Hongos/sangre , Femenino , Humanos , Masculino , Persona de Mediana Edad , Paracoccidioidomicosis/virología , Sensibilidad y EspecificidadRESUMEN
One of the most characteristic features of the chromoblastomycosis is its unresponsiveness to treatment. In order to analyzed whether during therapy could be observed a change of cellular immune response pattern, we evaluated the production of IL-10, TNF-alpha and IFN-gamma, as well as proliferation of peripheral blood mononuclear cell (PBMC) from patients in different periods of chemotherapy treatment. Our results showed that after 6 months of treatment cells from patients proliferated to fungal antigens and produced a significant level of IFN-gamma. However, after 1 year of treatment a low proliferation of T cells and production of IFN-gamma accompanied by an increase of IL-10 were observed when compared with 6 months of treatment.
Asunto(s)
Antifúngicos/uso terapéutico , Cromoblastomicosis/tratamiento farmacológico , Cromoblastomicosis/inmunología , Linfocitos T/inmunología , Adulto , Anciano , Antígenos Fúngicos/inmunología , Ascomicetos/aislamiento & purificación , Proliferación Celular , Quimioterapia Combinada , Femenino , Humanos , Inmunidad Celular/inmunología , Interferón gamma/metabolismo , Interleucina-10/metabolismo , Itraconazol/uso terapéutico , Masculino , Persona de Mediana Edad , Naftalenos/uso terapéutico , Terbinafina , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
The present report describes a case of cutaneous protothecosis caused by Prototheca wickerhamii in a nonimmunocompromised Brazilian female. Dermatological examination revealed a 15-cm diffusely infiltrated eczema-like plaque recovered with many pustule-like lesions on the right forearm. We emphasize the mycological and pathological aspects of this infection that can lead to misdiagnosis. The patient was successfully treated with itraconazole.
Asunto(s)
Infecciones/diagnóstico , Prototheca/aislamiento & purificación , Enfermedades Cutáneas Infecciosas/diagnóstico , Anciano , Antifúngicos/uso terapéutico , Femenino , Antebrazo , Humanos , Inmunocompetencia , Infecciones/tratamiento farmacológico , Itraconazol/uso terapéutico , Enfermedades Cutáneas Infecciosas/tratamiento farmacológicoRESUMEN
The present report describes a case of onychoprotothecosis caused by Prototheca wickerhamii in a nonimmunocompromized female. Dermatological examination showed yellowish discoloration of the left and right forefinger nails, showing onicolysis and hyperkeratosis. The repeated isolation of the algae Prototheca (organisms morula-like) as well as the repeated culture in media, Sabouraud agar, confirmed the diagnosis. The patient was successfully treated with tioconazol 1% topic solution. The aim of this paper was to present a rare condition.
Asunto(s)
Infecciones/diagnóstico , Enfermedades de la Uña/diagnóstico , Prototheca/crecimiento & desarrollo , Brasil , Femenino , Humanos , Imidazoles/uso terapéutico , Infecciones/tratamiento farmacológico , Infecciones/microbiología , Persona de Mediana Edad , Enfermedades de la Uña/tratamiento farmacológico , Enfermedades de la Uña/microbiología , Prototheca/efectos de los fármacos , Prototheca/aislamiento & purificación , Resultado del TratamientoRESUMEN
FUNDAMENTO: Apesar de a porfiria cutânea tardia ser a mais frequente das porfirias, há poucos estudos que abordam sua fisiopatologia cutânea. OBJETIVO: Avaliar as alterações cutâneas na porfiria cutânea tardia utilizando a microscopia ótica e a imunofluorescência direta, antes e depois do tratamento com cloroquina. Realizar o imunomapeamento antigênico da bolha para estudo do seu nível de clivagem. MÉTODOS: Relata-se a microscopia ótica e imunofluorescência direta de 28 pacientes em três fases diferentes: 23 pacientes com porfiria ativa antes do tratamento (Fase A), sete pacientes com remissão clínica durante o tratamento (Fase B) e oito pacientes com remissão bioquímica (Fase C). O imunomapeamento foi realizado em sete pacientes. RESULTADOS: Na porfiria ativa, a imunofluorescência direta demonstrou fluorescência homogênea e intensa no interior e na parede dos vasos e na junção dermoepidérmica. Na remissão clínica (Fase B) e na remissão bioquímica (Fase C), o depósito de imunoglobulinas se manteve, mas o depósito de complemento apresentou diminuição na maioria. O imunomapeamento não demonstrou plano de clivagem fixo. CONCLUSÃO: Não houve correlação entre a resposta clínica e os depósitos de imunoglobulinas. A diminuição do complemento favorece a hipótese de que a ativação da cascata do complemento representa uma via adicional que leva à lesão endotelial.
BACKGROUND: Even though porphyria cutanea tarda is the most frequent type of porphyria, there are few studies about its cutaneous physiopathology. OBJECTIVE: To evaluate skin changes in porphyria cutanea tarda using light microscopy and direct immunofluorescence before and after treatment with chloroquine. To perform antigen immunomapping of bullae to study their level of cleavage. METHODS: Light microscopy and direct immunofluorescence of 28 patients are reported in three different phases: 23 patients with active porphyria before treatment (Phase A), 7 patients with clinical remission during treatment (Phase B), and 8 patients with biochemical remission (Phase C). Immunomapping was performed on 7 patients. RESULTS: In active porphyria, direct immunofluorescence showed homogenous and intense fluorescence on the inside and on the walls of blood vessels as well as in the dermal-epidermal junction. In clinical remission (Phase B) and biochemical remission (Phase C), the deposit of immunoglobulins was maintained, but the deposit of complement was reduced in most cases. Immunomapping revealed no standard cleavage plane. CONCLUSION: No correlation was observed between clinical response and immunoglobulin deposits. The reduction of complement favors the hypothesis that activation of the complement cascade represents an additional pathway that leads to endothelial damage.
Asunto(s)
Adolescente , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Porfiria Cutánea Tardía/fisiopatología , Anticuerpos Monoclonales/inmunología , Antígenos/inmunología , Estudios Transversales , Cloroquina/uso terapéutico , Fármacos Dermatológicos/uso terapéutico , Técnica del Anticuerpo Fluorescente Directa , Microscopía/métodos , Porfiria Cutánea Tardía/tratamiento farmacológico , Porfiria Cutánea Tardía/inmunologíaRESUMEN
O escopo deste artigo é revisar os estados de hipercoagulabilidade sangüínea (trombofilias) mais provavelmente encontrados por dermatologista. Seus sinais cutâneos incluem o livedo reticular, necrose cutânea, ulcerações e isquemia digital, púrpura retiforme, além de úlceras nas pernas. Revisamos seu tratamento adequado, bem como ressaltamos as manifestações cutâneas que impõem pesquisa laboratorial de trombofilias e os exames indicados nessas situações.
The aim of this article is to review the hypercoagulable states (thrombophilia) most probably found by dermatologists; their cutaneous signs including livedo racemosa, skin necrosis, digital ischemia and ulcerations, retiform purpura and leg ulcers; their appropriate treatment; to describe the skin manifestations that require laboratory tests for thrombophilias and the tests indicated in these clinical conditions.
Asunto(s)
Dermatomicosis/epidemiología , Dermatomicosis/etiología , Agricultura Forestal , Adolescente , Adulto , Distribución por Edad , Brasil/epidemiología , Niño , Estudios de Cohortes , Femenino , Humanos , Masculino , Persona de Mediana Edad , Onicomicosis/epidemiología , Onicomicosis/etiología , Prevalencia , Índice de Severidad de la Enfermedad , Distribución por Sexo , Tiña/epidemiología , Tiña/etiología , Tiña del Cuero Cabelludo/epidemiología , Tiña del Cuero Cabelludo/etiología , Tiña del Pie/epidemiología , Tiña del Pie/etiologíaRESUMEN
Cryptococcus neoformans is an encapsulated fungal organism that can cause disease in apparently immunocompetent, as well as immunocompromised, hosts. Since 1930, successive subculture has been used to preserve C. neoformans isolates in our Fungus Collection. In the 1970s, some of these Fungus Collection samples were selected to be subjected to a different methods of maintenance - that of lyophilized. Our objective was to analyze C. neoformans isolates in order to make a comparative evaluation between these two methods of preservation. The overall aim of this study was to qualify the preservation technique used in our mycology laboratory since the technique used might affect the survival, stability and purity of the primary isolates in culture. The samples were analyzed using classical mycology methods and using the randomly amplified polymorphic DNA technique In the analysis of phenotypes and genotypes, the typical characteristics of C. neoformans were found to differ in relation to the different methods of preservation employed. The aim of this study was to demonstrate the importance of selecting the appropriate method of preservation for fungus collections. This selection can affect the survival and purity of the cultures, and preserve the stability of their physiological, biochemical, and genetic characteristics.
Asunto(s)
Humanos , Cryptococcus neoformans/genética , ADN de Hongos/análisis , Preservación Biológica/métodos , Cryptococcus neoformans/fisiología , Liofilización , Genotipo , Fenotipo , Reacción en Cadena de la Polimerasa , Técnica del ADN Polimorfo Amplificado Aleatorio , Factores de TiempoRESUMEN
Trata-se de revisão sobre a porfiria cutânea tardia em que são abordados a fisiopatogenia, as características clínicas, as doenças associadas, os fatores desencadeantes, a bioquímica, a histopatologia, a microscopia eletrônica, a microscopia de imunofluorescência e o tratamento da doença.
This is a review article of porphyria cutanea tarda addressing pathophysiology, clinical features, associated conditions, triggering factors, biochemistry, histopathology, electronic microscopy, immunofluorescence microscopy and treatment of the disease.
RESUMEN
The aim of this study was to demonstrate the DNA of Paracoccidioides brasiliensis in human serum samples of patients with paracoccidioidomycosis using the polymerase chain reaction (PCR). The diagnosis of paracoccidioidomycosis (PCM) was defined by microscopic observation of the fungus on direct exam or histopathology, culture, and serological positivity. DNA from serum of 33 patients with PCM was extracted and submitted to nested-PCR using primers from the gp 43 gene. Only one sample was positive on nested-PCR. We conclude that the prevalence of fungemia in patients with different clinical forms of PCM is low, limiting the use of serum DNA detection as an alternative diagnostic tool.
Asunto(s)
Humanos , Masculino , Femenino , Niño , Adulto , Persona de Mediana Edad , Antígenos Fúngicos/genética , ADN de Hongos/análisis , Fungemia/diagnóstico , Glicoproteínas/genética , Paracoccidioides/genética , Paracoccidioidomicosis/sangre , Proteínas Fúngicas/genética , Reacción en Cadena de la Polimerasa/métodos , ADN de Hongos/sangre , Cartilla de ADN , Paracoccidioidomicosis/virología , Sensibilidad y EspecificidadRESUMEN
OBJETIVO: A uréia é comumente usada como substância queratolítica no tratamento das onicomicoses no intuito de melhorar a penetração das drogas antifúngicas. O objetivo deste estudo foi investigar a ação inibitória in vitro da uréia em amostras de dermatófitos. MÉTODOS: A concentração inibitória mínima da uréia foi determinada para trinta e uma amostras de dermatófitos semeadas em meio de cultura Sabouraud-dextrose contendo diferentes concentrações (7,5% até 40%) de uréia. usência de crescimento foi o critério adotado para a determinação da concentração inibitória mínima. RESULTADOS: A maioria das amostras (87%) foi sensível à uréia em concentrações de 12,5% ou menos. Apenas dois isolados de Trichophyton tonsurans e dois de Trichophyton rubrum foram inibidos completamente na presença de 30% e 40% de uréia, respectivamente. CONCLUSÃO: Os resultados in vitro demonstraram atividade inibitória da uréia sobre os dermatófitos, sugerindo que possa ser usada como um adjuvante em tratamentos tópicos.
Asunto(s)
Humanos , Antifúngicos/farmacología , Queratolíticos/farmacología , Microsporum/efectos de los fármacos , Trichophyton/efectos de los fármacos , Urea/farmacología , Medios de Cultivo , Pruebas de Sensibilidad MicrobianaRESUMEN
Nosso propósito foi comparar o polimorfismo genético de seis amostras de P. brasiliensis (113, 339, BAT, T1F1, T3B6, T5LN1), com quatro amostras de P. cerebriformis (735, 741, 750, 361) do laboratório de micologia do Instituto de Medicina Tropical de São Paulo, utilizando a técnica de Amplificação Aleatória do Polimorfismo de DNA (RAPD). O perfil de bandas do RAPD diferenciou claramente os isolados de P. brasiliensis de P. cerebriformis. Entretanto, ocorreu uma variação significativa no padrão de bandas das amostras de P. cerebriformis. O sequenciamento do gene ribossomal 28S revelou seqüências de nucleotídeos bastante conservadas entre os isolados de P. cerebriformis, fornecendo subsídio para o agrupamento taxonômico destas amostras, diferenciando estas de P. brasiliensis e mostrando que de fato são espécies distintas. A seqüência de DNA sugere que P. cerebriformis pertence ao gênero Aspergillus.
Asunto(s)
Humanos , ADN de Hongos/aislamiento & purificación , ADN Ribosómico/genética , Paracoccidioides/genética , Polimorfismo Genético/genética , Análisis de Secuencia de ADN , Secuencia de Bases , ADN de Hongos/genética , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Paracoccidioides/clasificación , Técnica del ADN Polimorfo Amplificado AleatorioRESUMEN
A urticária apresenta-se com diversas formas clínicas e causas distintas. Constitui uma das dermatoses mais freqüentes: 15% a 20% da população têm pelo menos um episódio agudo da doença em sua vida, resultando em percentual que varia de um a 2% dos atendimentos nas especialidades de Dermatologia e Alergologia. A urticária é classificada do ponto de vista de duração da evolução temporal em aguda (inferior a seis semanas) ou crônica (superior a seis semanas). O tratamento da urticária pode compreender medidas não farmacológicas e intervenções medicamentosas, as quais são agrupadas em tratamentos de primeira (anti-histamínicos), segunda (corticosteróides e antileucotrienos) e terceira linha (medicamentos imunomoduladores).As medidas terapêuticas de segunda e terceira linha apresentam maiores efeitos adversos, devendo ser reservadas aos doentes que não apresentaram controle da doença com os de primeira linha, ou àqueles a respeito dos quais não é possível estabelecer uma etiologia, tal como nas urticárias auto-imunes
Asunto(s)
Corticoesteroides , Ciclosporina , Histamina , Antagonistas de los Receptores Histamínicos , Antagonistas de los Receptores Histamínicos H1 , Antagonistas de los Receptores H2 de la Histamina , Mastocitos , Prostaglandinas , UrticariaRESUMEN
Apresentaçäo de um doente, de 45 dias, com tinha na face por Microsporum canis. O quadro surgiu no quarto dia de vida e foi exacerbado pelo uso indevido de corticóide tópico. Os autores revisam a literatura onde säo relatados três casos em recém-nascidos com tinha da face pelo Microsporum canis